Thus, we conclude that high SCD expression indicates poor prognosis in patients with bladder urothelial cancer, and the blockade of SCD gene activity significantly inhibits the proliferation and invasion of bladder cancer cells. The gene discussed is SCD; the disease is bladder transitional cell carcinoma.